CoChat

Review article: the therapeutic potential of 5‐HT3receptor antagonists in the treatment of irritable bowel syndrome

Open access
Humphrey, P.P.A., Bountra, C., Clayton, N., Kozlowski, K. · 1999 · Alimentary Pharmacology & Therapeutics
Cited by 94

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Abstract

There is evidence from studies, in both animals and humans, that 5‐HT 3 receptor blockade has potential value in the treatment of irritable bowel syndrome, particularly in those patients with diarrhoea‐predominant bowel habits. New findings suggest that 5‐HT 3 receptors exist on gut afferent neurones and that their activation by locally released 5‐HT leads to visceral nociceptive stimulation, in addition to increased neuronally‐mediated motor and secretory activity. If this concept is validated, it will provide a rationale for the use of 5‐HT 3 receptor antagonists in patients with increased gut motility, reduced fluid absorption and low nociceptive thresholds leading to abdominal pain. Alosetron is a highly selective, potent 5‐HT 3 receptor antagonist which is well absorbed with a long pharmacodynamic half‐life. Its ability to provide long‐lasting blockade of 5‐HT 3 receptors throughout the body make it an ideal candidate within its class to evaluate the clinical hypothesis that sustained and ubiquitous 5‐HT 3 receptor blockade is of value in the treatment of IBS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2036.1999.00003.x-i2

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 1 references

Metadata

Authors
Humphrey, P. P. A., Bountra, C., Clayton, N., & Kozlowski, K.
Venue
Alimentary Pharmacology & Therapeutics
Publisher
Wiley
Published
1999-05
Volume
13
Issue
s2
Pages
31-38
ISSN
  • 0269-2813 (ISSN-L)
  • 1365-2036
OpenAlex
W2083665563
Cited by
94
References
1
FWCI
6.72
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Review article: the therapeutic potential of 5‐HT3receptor antagonists in the treatment of irritable bowel syndrome. https://app.cochat.ai/papers/10.1046/j.1365-2036.1999.00003.x-i2
The paper
Humphrey, P. P. A., Bountra, C., Clayton, N., & Kozlowski, K. (1999). Review article: the therapeutic potential of 5‐HT3receptor antagonists in the treatment of irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. https://doi.org/10.1046/j.1365-2036.1999.00003.x-i2

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.